MSB 4.00% $1.17 mesoblast limited

Ann: P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment, page-13

  1. 19,272 Posts.
    lightbulb Created with Sketch. 6369
    Well this announcement is delivering on the promise. We are now in the final countdown to knowing if CHF trial is a dud or a success.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.